Showing results (621-630 of 831) with videos related to
Sort By:
Pageof 84
Blood|August 27, 2005
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemiaStefan Faderl, Kim-Anh Do, Marcella M Johnson, et al.Blood|May 7, 2014
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemiaNatali Pflug, Jasmin Bahlo, Tait D Shanafelt, et al.Cancer Genetics and Cytogenetics|December 16, 2010
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research ConsortiumStephanie A Smoley, Daniel L Van Dyke, Neil E Kay, et al.Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.Blood|April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLLSameer A Parikh, Kari G Rabe, Neil E Kay, et al.Leukemia Research|July 31, 2007
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning, Susan M Geyer, Amy J Johnson, et al.The Oncologist|September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic LeukemiaPaul J Hampel, Timothy G Call, Kari G Rabe, et al.Blood|October 22, 2009
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Thomas J Kipps, Ian W Flinn, et al.Blood|April 30, 2014
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cellsUri Rozovski, Ji Yuan Wu, David M Harris, et al.Cancer|December 22, 2017
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phaseKoji Sasaki, Hagop Kantarjian, Susan O'Brien, et al.Pageof 84